Regents of the University of California’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Regents of the University of California’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,928	Closed	-$768K	–	33
2020 Q3	$768K	Hold	13,928	–	–	0.11%	19
2020 Q2	$879K	Hold	13,928	–	–	0.12%	18
2020 Q1	$712K	Hold	13,928	–	–	0.11%	18
2019 Q4	$1.11M	Hold	13,928	–	–	0.58%	15
2019 Q3	$676K	Hold	13,928	–	–	1.29%	20
2019 Q2	$733K	Hold	13,928	–	–	2.07%	17
2019 Q1	$673K	Hold	13,928	–	–	1.58%	16
2018 Q4	$572K	Hold	13,928	–	–	1.38%	19
2018 Q3	$529K	Hold	13,928	–	–	1.03%	19
2018 Q2	$630K	Hold	13,928	–	–	1.65%	15
2018 Q1	$673K	Hold	13,928	–	–	1.23%	16
2017 Q4	$548K	Buy	+13,928	New	+$520K	0.83%	22

Other funds holding GBT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Regents of the University of California's GBT Position: Q4 2020 in Review

Regents of the University of California sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2020, closing a stake of 13,928 shares — an estimated $768K sold.

Regents of the University of California first reported a position in GBT in Q4 2017 and held it in 12 quarters. The position peaked at $1.11M in Q4 2019. 228 funds tracked by Wall St. Rank hold GBT as of Q4 2020.

Regents of the University of California reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
Regents of the University of California sold 13,928 Global Blood Therapeutics, Inc. shares in Q4 2020, an estimated $768K.
Regents of the University of California first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 12 quarters.
Regents of the University of California's Global Blood Therapeutics, Inc. position peaked at $1.11M in Q4 2019.
228 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2020.

Based on Regents of the University of California's 13F filing for Q4 2020, filed 21 Jan 2021.